To start off our mini-series on ALL, this episode we’ll be looking at adolescent and young adult (AYA) patients. Although these patients are commonly seen in the adult setting, evidence suggests that pediatric-inspired regimens may improve their outcomes. But how should these be implemented practically? Joining us this week is Dr Adam DuVall, Assistant Professor of Medicine and specialist in AYA cancer management at the University of Chicago.
Access more free education today! Visit the website, follow us on Twitter (@onckip) or connect on LinkedIn.
References:
- Terwilliger T, Abdul-Hay M. Blood Cancer Journal 2019; 7:e577
- Muffly L, et al. Blood Adv. 2018; 2(8):895-903
- Siegel SE, et al. JAMA Oncol. 2018; 4(5):725-734
- Stock W, et al. Blood. 2019; 133(14):1548-1559

This independent educational activity is supported by educational grants from Servier Pharmaceuticals LLC and Takeda. The educational content has been developed by Liberum IME in conjunction with an independent steering committee; Servier and Takeda have had no influence on the content of this education.